Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study

BACKGROUND: The objective of this study was to evaluate the effect of ribavirin and recombinant interferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syndrome (MERS), accounting for time-varying confounders. METHODS: This is a retrospective cohort stud...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Arabi, Yaseen M, Shalhoub, Sarah, Mandourah, Yasser, Al-Hameed, Fahad, Al-Omari, Awad, Al Qasim, Eman, Jose, Jesna, Alraddadi, Basem, Almotairi, Abdullah, Al Khatib, Kasim, Abdulmomen, Ahmed, Qushmaq, Ismael, Sindi, Anees A, Mady, Ahmed, Solaiman, Othman, Al-Raddadi, Rajaa, Maghrabi, Khalid, Ragab, Ahmed, Al Mekhlafi, Ghaleb A, Balkhy, Hanan H, Al Harthy, Abdulrahman, Kharaba, Ayman, Gramish, Jawaher A, Al-Aithan, Abdulsalam M, Al-Dawood, Abdulaziz, Merson, Laura, Hayden, Frederick G, Fowler, Robert
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Articles and Commentaries
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108209/
https://ncbi.nlm.nih.gov/pubmed/31925415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz544
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi